CY1K Fundamental Analysis - SBF AG

Fundamental Rating

CY1K gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 67 industry peers in the Electrical Equipment industry. CY1K scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CY1K is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

CY1K had negative earnings in the past year.

In the past year CY1K has reported a negative cash flow from operations.

The reported net income has been mixed in the past 5 years: CY1K reported negative net income in multiple years.

The reported operating cash flow has been mixed in the past 5 years: CY1K reported negative operating cash flow in multiple years.

1.2 Ratios

CY1K's Return On Assets of -4.03% is on the low side compared to the rest of the industry. CY1K is outperformed by 62.69% of its industry peers.

CY1K has a Return On Equity (-6.32%) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-4.03%
ROE	-6.32%
ROIC	N/A

ROA(3y)-4.25%

ROA(5y)1.07%

ROE(3y)-6.03%

ROE(5y)2.13%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 47.99%, CY1K is in the better half of the industry, outperforming 68.66% of the companies in the same industry.

In the last couple of years the Gross Margin of CY1K has declined.

CY1K does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	47.99%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.52%

GM growth 5Y-3.06%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CY1K does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for CY1K remains at a similar level compared to 1 year ago.

The number of shares outstanding for CY1K has been increased compared to 5 years ago.

The debt/assets ratio for CY1K has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 3.72 indicates that CY1K is not in any danger for bankruptcy at the moment.

CY1K has a better Altman-Z score (3.72) than 71.64% of its industry peers.

A Debt/Equity ratio of 0.00 indicates that CY1K is not too dependend on debt financing.

CY1K's Debt to Equity ratio of 0.00 is amongst the best of the industry. CY1K outperforms 95.52% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	3.72

ROIC/WACCN/A

WACC8.02%

2.3 Liquidity

CY1K has a Current Ratio of 5.56. This indicates that CY1K is financially healthy and has no problem in meeting its short term obligations.

With an excellent Current ratio value of 5.56, CY1K belongs to the best of the industry, outperforming 98.51% of the companies in the same industry.

A Quick Ratio of 2.04 indicates that CY1K has no problem at all paying its short term obligations.

With an excellent Quick ratio value of 2.04, CY1K belongs to the best of the industry, outperforming 88.06% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	5.56
Quick Ratio	2.04

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.00% over the past year.

Looking at the last year, CY1K shows a very strong growth in Revenue. The Revenue has grown by 38.99%.

Measured over the past years, CY1K shows a very strong growth in Revenue. The Revenue has been growing by 22.84% on average per year.

EPS 1Y (TTM)40%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%65.52%

Revenue 1Y (TTM)38.99%

Revenue growth 3Y14.83%

Revenue growth 5Y22.84%

Sales Q2Q%42.09%

3.2 Future

CY1K is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 67.11% yearly.

The Revenue is expected to grow by 6.51% on average over the next years.

EPS Next Y95.83%

EPS Next 2Y90.39%

EPS Next 3Y67.11%

EPS Next 5YN/A

Revenue Next Year-3.76%

Revenue Next 2Y3.8%

Revenue Next 3Y5.27%

Revenue Next 5Y6.51%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CY1K. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CY1K. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

70.15% of the companies in the same industry are cheaper than CY1K, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	157.01

4.3 Compensation for Growth

A more expensive valuation may be justified as CY1K's earnings are expected to grow with 67.11% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y90.39%

EPS Next 3Y67.11%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CY1K!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

SBF AG

FRA:CY1K (12/18/2025, 7:00:00 PM)

5.85

-0.25 (-4.1%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryElectrical Equipment

Earnings (Last)10-15 2025-10-15

Earnings (Next)N/A N/A

Inst Owners11.22%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap56.80M

Revenue(TTM)47.20M

Net Income(TTM)-1.99M

Analysts86.67

Price Target9.04 (54.53%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-10.5%

PT rev (3m)1.17%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-3.09%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.2
P/FCF	N/A
P/OCF	N/A
P/B	1.8
P/tB	1.81
EV/EBITDA	157.01

EPS(TTM)-0.21

EYN/A

EPS(NY)-0.01

Fwd EYN/A

FCF(TTM)-0.28

FCFYN/A

OCF(TTM)-0.17

OCFYN/A

SpS4.86

BVpS3.24

TBVpS3.24

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-4.03%
ROE	-6.32%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	47.99%
FCFM	N/A

ROA(3y)-4.25%

ROA(5y)1.07%

ROE(3y)-6.03%

ROE(5y)2.13%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.52%

GM growth 5Y-3.06%

F-Score5

Asset Turnover0.96

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	0.02
Cap/Depr	68.48%
Cap/Sales	2.16%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	5.56
Quick Ratio	2.04
Altman-Z	3.72

F-Score5

WACC8.02%

ROIC/WACCN/A

Cap/Depr(3y)99.31%

Cap/Depr(5y)148.34%

Cap/Sales(3y)5.49%

Cap/Sales(5y)6.81%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)40%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%65.52%

EPS Next Y95.83%

EPS Next 2Y90.39%

EPS Next 3Y67.11%

EPS Next 5YN/A

Revenue 1Y (TTM)38.99%

Revenue growth 3Y14.83%

Revenue growth 5Y22.84%

Sales Q2Q%42.09%

Revenue Next Year-3.76%

Revenue Next 2Y3.8%

Revenue Next 3Y5.27%

Revenue Next 5Y6.51%

EBIT growth 1Y53.81%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year270.86%

EBIT Next 3Y127.39%

EBIT Next 5Y72.84%

FCF growth 1Y-112.55%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-343.31%

OCF growth 3YN/A

OCF growth 5YN/A

SBF AG / CY1K.DE FAQ

Can you provide the ChartMill fundamental rating for SBF AG?

ChartMill assigns a fundamental rating of 3 / 10 to CY1K.DE.

Can you provide the valuation status for SBF AG?

ChartMill assigns a valuation rating of 1 / 10 to SBF AG (CY1K.DE). This can be considered as Overvalued.

What is the profitability of CY1K stock?

SBF AG (CY1K.DE) has a profitability rating of 1 / 10.

SBF AG (CY1K.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

SBF AG / CY1K.DE FAQ

Can you provide the ChartMill fundamental rating for SBF AG?

Can you provide the valuation status for SBF AG?

What is the profitability of CY1K stock?